India is confronting a severe public health crisis with antibiotic resistance, where nearly 35% of bacterial infections are resistant to first-line antibiotics, according to data from the Indian Council of Medical Research (ICMR). Particularly alarming is the drop in susceptibility to carbapenems, a last-resort treatment, which has fallen below 30% for dangerous strains like Klebsiella pneumoniae. The distinction between antibiotic resistance and tolerance is vital; resistance is a permanent genetic change that allows bacteria to thrive despite treatment, while tolerance is a temporary state where bacteria enter dormancy, evading the effects of antibiotics. This understanding is crucial in a country where self-medication is prevalent and can lead to incomplete treatment courses, allowing tolerant bacteria to survive and potentially mutate into resistant strains. The Indian healthcare system faces unique challenges due to high population density and easy access to antibiotics, which contribute to the rise of superbugs. To combat this, healthcare strategies must focus on completing antibiotic courses, improving diagnostic accuracy, and avoiding unnecessary antibiotic use for viral infections. Addressing these issues is essential to prevent the reality of a 'Post-Antibiotic Era' where common infections could become untreatable.